In addition, T cells are the primary cell type in tumor immunity; among them, CD4+ subtypes could modulate the anti-tumor immunity via secreting cytokines, while CD8+ subtypes could conduct the secretion of specific inhibitory cytokines, including IFN-γ and TNF-α. Here, TNF is linked to neoplasm.